ISNS:图像传感系统
1.具有成长性,
2.内部买入.成本6.5-6.8美间之间.
3.目标价:13-15美金之间.
LMNL:出卖了血浆业务。
Liminal将从出售优先审查凭证中获得最多70%的净收益,它可能有资格获得FDA对Ryplazim的批准.6.5纵然批准,含金量大打折扣,不过别...查看全文
HinvestLetter2016-08-22 18:41
报告作者:Harry Wu 报告出处:Harry's InvestLetter
相关股票:$图像传感系统(ISNS)$ $Digital Ally(DGLY)$ $美国生科ETF-iShares(IBB)$
美股投资InvestLetter Beta版,开放阅读。
网页链接查看全文
【行情】图像传感系统(ISNS.O)盘前跌幅扩大至27%,第一季度销售额同比下降5.7%。 图像传感系统(ISNS.O)盘前跌幅扩大至27%,第一季度销售额同比下降5.7%。 网页链接
$图像传感系统(ISNS)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2017-03-31 AccNo: 0000943034-17-000028 Size: 250 KB 网页链接
$图像传感系统(ISNS)$ DEF 14A - Other definitive proxy statements Filed: 2017-03-31 AccNo: 0000943034-17-000026 Size: 733 KB 网页链接
$图像传感系统(ISNS)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2017-03-24 AccNo: 0000943034-17-000021 Size: 5 MB 网页链接
$图像传感系统(ISNS)$ 8-K - Current report Filed: 2017-03-23 AccNo: 0000943034-17-000015 Size: 250 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$图像传感系统(ISNS)$ PRE 14A - Other preliminary proxy statements Filed: 2017-03-22 AccNo: 0000943034-17-000012 Size: 733 KB 网页链接
$图像传感系统(ISNS)$ 8-K - Current report Filed: 2017-03-14 AccNo: 0000943034-17-000003 Size: 30 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$图像传感系统(ISNS)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2016-11-10 AccNo: 0000943034-16-000030 Size: 3 MB 网页链接
$图像传感系统(ISNS)$ 8-K - Current report Filed: 2016-11-10 AccNo: 0000943034-16-000028 Size: 249 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$图像传感系统(ISNS)$ 8-K - Current report Filed: 2016-11-02 AccNo: 0000943034-16-000022 Size: 55 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$图像传感系统(ISNS)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2016-10-11 AccNo: 0001140361-16-082352 Size: 108 KB 网页链接